Global Genomics In Cancer Care Market Research Report 2022

Global Genomics In Cancer Care Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2017-2028)
2.2 Genomics In Cancer Care Growth Trends by Region
2.2.1 Genomics In Cancer Care Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genomics In Cancer Care Historic Market Size by Region (2017-2022)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2023-2028)
2.3 Genomics In Cancer Care Market Dynamics
2.3.1 Genomics In Cancer Care Industry Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Revenue
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2017-2022)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2017-2022)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2021
3.5 Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2017-2022)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2017-2022)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2017-2028)
6.2 North America Genomics In Cancer Care Market Size by Country (2017-2022)
6.3 North America Genomics In Cancer Care Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2017-2028)
7.2 Europe Genomics In Cancer Care Market Size by Country (2017-2022)
7.3 Europe Genomics In Cancer Care Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics In Cancer Care Market Size (2017-2028)
8.2 Asia-Pacific Genomics In Cancer Care Market Size by Country (2017-2022)
8.3 Asia-Pacific Genomics In Cancer Care Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Genomics In Cancer Care Market Size (2017-2028)
9.2 Latin America Genomics In Cancer Care Market Size by Country (2017-2022)
9.3 Latin America Genomics In Cancer Care Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics In Cancer Care Market Size (2017-2028)
10.2 Middle East & Africa Genomics In Cancer Care Market Size by Country (2017-2022)
10.3 Middle East & Africa Genomics In Cancer Care Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2017-2022)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Detail
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2017-2022)
11.2.5 Thermo Fisher scientific Recent Development
11.3 Agilent
11.3.1 Agilent Company Detail
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2017-2022)
11.3.5 Agilent Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Detail
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2017-2022)
11.5.5 Cancer Genetics Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Detail
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2017-2022)
11.6.5 Beckman Coulter Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2017-2022)
11.7.5 Bio-Rad Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2017-2022)
11.8.5 Danaher Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Detail
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2017-2022)
11.9.5 Sigma Aldrich Recent Development
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Detail
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2017-2022)
11.10.5 Pacific Biosciences Recent Development
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Detail
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2017-2022)
11.11.5 Quest Diagnostics Recent Development
11.12 Luminex
11.12.1 Luminex Company Detail
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2017-2022)
11.12.5 Luminex Recent Development
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Detail
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2017-2022)
11.13.5 Oxford Gene Technology Recent Development
11.14 PerkinElmer
11.14.1 PerkinElmer Company Detail
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2017-2022)
11.14.5 PerkinElmer Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Detail
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2017-2022)
11.15.5 Qiagen Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Detail
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2017-2022)
11.16.5 GE Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Genomics In Cancer Care Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Genomics In Cancer Care Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Genomics In Cancer Care Market Share by Region (2017-2022)
Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Region (2023-2028)
Table 11. Genomics In Cancer Care Market Trends
Table 12. Genomics In Cancer Care Market Drivers
Table 13. Genomics In Cancer Care Market Challenges
Table 14. Genomics In Cancer Care Market Restraints
Table 15. Global Genomics In Cancer Care Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Genomics In Cancer Care Market Share by Players (2017-2022)
Table 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
Table 18. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genomics In Cancer Care Product Solution and Service
Table 22. Date of Enter into Genomics In Cancer Care Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2017-2022)
Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2023-2028)
Table 28. Global Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Genomics In Cancer Care Revenue Market Share by Application (2017-2022)
Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Genomics In Cancer Care Revenue Market Share by Application (2023-2028)
Table 32. North America Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Genomics In Cancer Care Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Genomics In Cancer Care Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 42. Illumina Company Detail
Table 43. Illumina Business Overview
Table 44. Illumina Genomics In Cancer Care Product
Table 45. Illumina Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 46. Illumina Recent Development
Table 47. Thermo Fisher scientific Company Detail
Table 48. Thermo Fisher scientific Business Overview
Table 49. Thermo Fisher scientific Genomics In Cancer Care Product
Table 50. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 51. Thermo Fisher scientific Recent Development
Table 52. Agilent Company Detail
Table 53. Agilent Business Overview
Table 54. Agilent Genomics In Cancer Care Product
Table 55. Agilent Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 56. Agilent Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche Genomics In Cancer Care Product
Table 60. Roche Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 61. Roche Recent Development
Table 62. Cancer Genetics Company Detail
Table 63. Cancer Genetics Business Overview
Table 64. Cancer Genetics Genomics In Cancer Care Product
Table 65. Cancer Genetics Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 66. Cancer Genetics Recent Development
Table 67. Beckman Coulter Company Detail
Table 68. Beckman Coulter Business Overview
Table 69. Beckman Coulter Genomics In Cancer Care Product
Table 70. Beckman Coulter Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 71. Beckman Coulter Recent Development
Table 72. Bio-Rad Company Detail
Table 73. Bio-Rad Business Overview
Table 74. Bio-Rad Genomics In Cancer Care Product
Table 75. Bio-Rad Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 76. Bio-Rad Recent Development
Table 77. Danaher Company Detail
Table 78. Danaher Business Overview
Table 79. Danaher Genomics In Cancer Care Product
Table 80. Danaher Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 81. Danaher Recent Development
Table 82. Sigma Aldrich Company Detail
Table 83. Sigma Aldrich Business Overview
Table 84. Sigma Aldrich Genomics In Cancer Care Product
Table 85. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 86. Sigma Aldrich Recent Development
Table 87. Pacific Biosciences Company Detail
Table 88. Pacific Biosciences Business Overview
Table 89. Pacific Biosciences Genomics In Cancer Care Product
Table 90. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 91. Pacific Biosciences Recent Development
Table 92. Quest Diagnostics Company Detail
Table 93. Quest Diagnostics Business Overview
Table 94. Quest Diagnostics Genomics In Cancer CareProduct
Table 95. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 96. Quest Diagnostics Recent Development
Table 97. Luminex Company Detail
Table 98. Luminex Business Overview
Table 99. Luminex Genomics In Cancer CareProduct
Table 100. Luminex Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 101. Luminex Recent Development
Table 102. Oxford Gene Technology Company Detail
Table 103. Oxford Gene Technology Business Overview
Table 104. Oxford Gene Technology Genomics In Cancer CareProduct
Table 105. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 106. Oxford Gene Technology Recent Development
Table 107. PerkinElmer Company Detail
Table 108. PerkinElmer Business Overview
Table 109. PerkinElmer Genomics In Cancer CareProduct
Table 110. PerkinElmer Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 111. PerkinElmer Recent Development
Table 112. Qiagen Company Detail
Table 113. Qiagen Business Overview
Table 114. Qiagen Genomics In Cancer CareProduct
Table 115. Qiagen Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 116. Qiagen Recent Development
Table 117. GE Healthcare Company Detail
Table 118. GE Healthcare Business Overview
Table 119. GE Healthcare Genomics In Cancer CareProduct
Table 120. GE Healthcare Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 121. GE Healthcare Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Share by Type: 2021 VS 2028
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Global Genomics In Cancer Care Market Share by Application in 2021 & 2028
Figure 6. Diagnostics Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Development Case Studies
Figure 10. Research Case Studies
Figure 11. Genomics In Cancer Care Report Years Considered
Figure 12. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Genomics In Cancer Care Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Genomics In Cancer Care Market Share by Region: 2021 VS 2028
Figure 15. Global Genomics In Cancer Care Market Share by Players in 2021
Figure 16. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2021
Figure 18. North America Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Genomics In Cancer Care Market Share by Country (2017-2028)
Figure 20. United States Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Genomics In Cancer Care Market Share by Country (2017-2028)
Figure 24. Germany Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Genomics In Cancer Care Market Share by Region (2017-2028)
Figure 32. China Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Genomics In Cancer Care Market Share by Country (2017-2028)
Figure 40. Mexico Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Genomics In Cancer Care Market Share by Country (2017-2028)
Figure 44. Turkey Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 47. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 48. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 49. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 50. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 51. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 52. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 53. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 54. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 55. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 56. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 57. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 58. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 59. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 60. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 61. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Agrigenomics Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 87

Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology. The global Agrigenomics market was valued at US$ 4849.2 million in 2023 and is anticipated to reach US$ 7524.5 million by 2030, witnessing a CAGR of 6.4% during The forecast period 2024-2030. Thermo Fisher Scientific,......

Global Agrigenomics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108

According to our LPI (LP Information) latest study, the global Agrigenomics market size was valued at US$ 4743.7 million in 2023. With growing demand in downstream market, the Agrigenomics is forecast to a readjusted size of US$ 7439.4 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Agrigenomics market. Agrigenomics are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Agrigenomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Agrigenomics market size was valued at USD 4989.6 million in 2023 and is forecast to a readjusted size of USD 7564.5 million by 2030 with a CAGR of 6.1% during review period. Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other t......

Global Gene Editing Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Merck - Horizo??n Discovery - Sangamo BioSciences - Integrated DNA Technologies - Lonza - New England Biolabs - ......

Global Agrigenomics Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 101

Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......

Global Agrigenomics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Agrigenomics market: According to our latest research, the global Agrigenomics market looks promising in the next 5 years. As of 2022, the global Agrigenomics market was estimated at USD 5139.47 million, and it's anticipated to reach USD 7676.54 million in 2028, with a CAGR of 6.92% during the forecast years. Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce. Application of genomics ......

Global Agrigenomics Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......

Global Genomics in Cancer Care Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Genomics in Cancer Care market: According to our latest research, the global Genomics in Cancer Care market looks promising in the next 5 years. As of 2022, the global Genomics in Cancer Care market was estimated at USD 4369.0 million, and it's anticipated to reach USD 11429.15 million in 2028, with a CAGR of 17.38% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......

Gene Editing Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 200

Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs